Vocabria and Pain - a phase IV clinical study of FDA data
Summary:
Pain is reported as a side effect among people who take Vocabria (cabotegravir sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rilpivirine, and have Hiv infection.
The phase IV clinical study analyzes which people have Pain when taking Vocabria. It is created by eHealthMe based on reports of 977 people who have side effects when taking Vocabria from the FDA, and is updated regularly.
What is Vocabria?
Vocabria has active ingredients of cabotegravir sodium. eHealthMe is studying from 977 Vocabria users. Check the latest studies of Vocabria.
What is Pain?
Pain is found to be associated with 3,809 drugs and 5,870 conditions by eHealthMe. Check the latest studies of Pain.
977 people reported to have side effects when taking Vocabria.
Among them, 25 people (2.56%) have Pain.

Among these 25 people:
How long have people been on Vocabria when they have Pain? *
- < 1 month: 57.14 %
- 1 - 6 months: 14.29 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 28.57 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Pain when taking Vocabria? *
- female: 38.89 %
- male: 61.11 %
What is the age of people who have Pain when taking Vocabria? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 18.18 %
- 30-39: 18.18 %
- 40-49: 9.09 %
- 50-59: 27.27 %
- 60+: 27.27 %
What are other drugs people take besides Vocabria? *
- Rilpivirine: 19 people, 76.00%
- Edurant: 13 people, 52.00%
- Truvada: 2 people, 8.00%
- Tivicay: 2 people, 8.00%
- Juluca: 2 people, 8.00%
- Biktarvy: 2 people, 8.00%
What are other side effects people have besides Pain? *
- Injection Site Pain: 9 people, 36.00%
- Headache (pain in head): 7 people, 28.00%
- Fatigue (feeling of tiredness): 6 people, 24.00%
- Nausea And Vomiting: 4 people, 16.00%
- Night Sweats (sweating in night): 4 people, 16.00%
- Fever: 4 people, 16.00%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 4 people, 16.00%
- Fainting (loss of consciousness and postural tone): 3 people, 12.00%
- Hypoaesthesia (reduced sense of touch or sensation): 3 people, 12.00%
- Hypersensitivity: 3 people, 12.00%
What are the existing conditions these people have? *
- Hiv Infection: 10 people, 40.00%
- Hiv Test Positive: 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Vocabria and have Pain?
- Check whether Pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vocabria:
- Vocabria (977 reports)
Pain treatments and more:
- Pain (1,140,595 reports)
How severe was Pain and when was it recovered:
Expand to all the drugs that have ingredients of cabotegravir sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vocabria:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pain:
- Pain (3,809 drugs)
Browse all the conditions that are associated with Pain:
- Pain (5,870 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cabotegravir sodium (the active ingredients of Vocabria) and Vocabria (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prilosec and Vitamin D2 drug interactions for women aged 50-59 - now
- Colecalciferol and Symbicort drug interactions for girls aged 10-19 - a second ago
- Duloxetine Hydrochloride and Urinary Incontinence Aggravated for Women aged 60+ - 3 seconds ago
- Weakness and drugs of ingredients of tiotropium bromide - 4 seconds ago
- Could Tramadol cause Mononeuritis? - 6 seconds ago
- Spiriva Respimat and Asthenia for Women aged 50-59 - 6 seconds ago
- Spiriva Respimat and Muscle Fatigue for Women aged 50-59 - 6 seconds ago
- Spiriva Respimat and Muscular Weakness for Women aged 50-59 - 7 seconds ago
- Spiriva Respimat and Lack Of Strength, Muscle Weakness, Weakness for Women aged 50-59 - 7 seconds ago
- Spiriva Respimat and Muscle Weakness for Women aged 50-59 - 7 seconds ago